KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · IEX Real-Time Price · USD
2.520
-0.010 (-0.40%)
At close: Jul 19, 2024, 4:00 PM
2.480
-0.040 (-1.59%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Company Description
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally.
It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.
Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.
The company was incorporated in 1980 and is based in Mahwah, New Jersey.
KORU Medical Systems, Inc.
| Country | United States |
| Founded | 1980 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 82 |
| CEO | Ms. Linda M. Tharby |
Contact Details
Address: 100 Corporate Drive Mahwah, New Jersey 07430 United States | |
| Phone | 845-469-2042 |
| Website | korumedical.com |
Stock Details
| Ticker Symbol | KRMD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000704440 |
| CUSIP Number | 759910102 |
| ISIN Number | US7599101026 |
| Employer ID | 13-3044880 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Linda M. Tharby | President, Chief Executive Officer and Director |
| Thomas Adams | Chief Financial Officer, Secretary and Treasurer |
| Brian Case | Chief Technology Officer |
| Kenneth Miller | Chief Commercial Officer |
| Christopher Pazdan | Senior Vice President of Operations |
| Rob Cannon | Vice President of Sales |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 10, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jul 10, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Jun 3, 2024 | 8-K | Current Report |
| May 23, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| May 14, 2024 | 8-K | Current Report |
| May 1, 2024 | 10-Q | Quarterly Report |
| May 1, 2024 | 8-K | Current Report |
| Apr 11, 2024 | 8-K | Current Report |
| Mar 28, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 18, 2024 | PRE 14A | Other preliminary proxy statements |